| |
1- Beal MF. Energetics in the pathogenesis of neurodegenerative diseases.
Trends Neurosci 2000;23:298-304.
2- Harper ME, Monemdjou S, Ramsey JJ, Weindruch R. Age-related increase
in mitochondrial proton leak and decrease in ATP turnover reactions in
mouse hepatocytes. Am J Physiol 1998; 275: E197-206.
3- Martin-Garcia J, Goldenthal MJ, Pierpont EM, Ananthakrishnan R, Perez-Atayde
A. Is age a contributory factor of mitochondrial bioenergetic decline
and DNA defects in idiopathic dilated cardiomyopathy? Cardiovasc Pathol
1999;8:217-222.
4- Pallardo FV, Asensi M, Garcia de la Asuncion J, Anton V, Lloret A,
Sastre J, Vina J. Late onset administration of oral antioxidants prevents
age-related loss of motor co-ordination and brain mitochondrial DNA damage.
Free Radic Res 1998; 29: 617-23.
5- Parkes TL, Elia AJ, Dickinson D, Hilliker AJ, Phillips JP, Boulianne
GL. Extension of Drosophila lifespan by overexpression of human SOD1 in
motorneurons. Nat Genet 1998;19:171-4.
6- Pereira C, Santos MS, Oliveira C. Involvement of oxidative stress
on the impairment of energy metabolism induced by A beta peptides on PC12
cells: protection by antioxidants. Neurobiol Dis 1999;6:209-219.
7-Reichmann H, Janetzky B. Mitochondrial dysfunction-a pathogenetic factor
in Parkinson's disease. J Neurology 2000;247 Suppl 2:II63-68.
8- Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury
P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled
trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's
disease. The Alzheimer's Disease Cooperative Study. N Engl J Med 1997;336:1216-1222.
9- Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial
decay in aging. Proc Natl Acad Sci U S A 1994;91:10771-10778.
10- Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, Mirra SS, Beal
MF, Yang CC, Gearing M, Salvo R, et al. Mitochondrial DNA variants observed
in Alzheimer disease and Parkinson disease patients. Genomics 1993;17:171-184.
|
|